TickerStat.com

BioStem Technologies, Inc. (BSEM)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Revenue$47.5M$69.7M
Gross profit$44.4M$55.9M
Research & development$7.1M$1.9M
Operating income−$689,147$31.1M
Net income$0$0
Diluted EPSper diluted share-$0.39$1.43
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗